GRIFFIN GIBSON: Open Payments
NPI 1104203439 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$379 in 19 payments from 9 companies in 2025. Trend: 2023 $93 · 2024 $166 · 2025 $379
Food & beverage: $379
| Company | Payments | Amount |
|---|---|---|
| Corium, LLC | 6 | $111 |
| Neurocrine BioSciences, Inc. | 2 | $59 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $51 |
| Indivior Inc. | 1 | $36 |
| Collegium Pharmaceutical, Inc. | 2 | $35 |
| Supernus Pharmaceuticals, Inc. | 2 | $29 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Tris Pharma Inc | 1 | $20 |
| Vertical Pharmaceuticals, LLC | 1 | $17 |
Products named: Azstarys, INGREZZA, TRINTELLIX, SUBLOCADE, Jornay PM, Qelbree, UZEDY, Dyanavel XR.
Industry payments across AL — which companies pay providers there.
